OpenAI Expands Life Sciences Model and Prepares for Public Offering
OpenAI is currently finalizing the necessary paperwork for its initial public offering on Wall Street. Alongside these financial preparations, the company has updated its model dedicated to the life sciences and established a new initiative focused on biodefense.
On June 3, 2026, the organization announced a major expansion of its Codex platform. Described as the most substantial growth since the platform's enterprise debut, the update introduces "Codex for every role, tool and workflow."
